Fed. Circ. Affirms Hospira Win In Generic Cubicin Patent Suit
The Federal Circuit on Thursday upheld a trial court's decision that four of five patents Merck & Co. Inc. holds for the blockbuster antibiotic Cubicin are invalid, a decision that could...To view the full article, register now.
Already a subscriber? Click here to view full article